REVANCE THERAPEUTICS INC shareholders Q1 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TILIA FIDUCIARY PARTNERS, INC. 600$19,3260.02%
J. Goldman & Co LP 13,500$434,8350.02%
Cape Investment Advisory, Inc. 877$28,2480.02%
SEI INVESTMENTS CO 286,151$9,216,9560.02%
Schonfeld Strategic Advisors LLC 55,001$1,771,5820.02%
EXENCIAL WEALTH ADVISORS, LLC 9,045$291,3400.02%
DENALI ADVISORS LLC 1,100$35,4310.02%
BNP PARIBAS FINANCIAL MARKETS 305,181$9,829,8800.01%
Ergoteles LLC 10,499$338,1730.01%
Kingsview Wealth Management, LLC 8,982$289,3100.01%
China Universal Asset Management Co., Ltd. 1,122$360.01%
Squarepoint Ops LLC 89,229$2,874,0660.01%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 33,062$1,0650.01%
Stephens Consulting, LLC 500$16,1050.01%
MetLife Investment Management, LLC 42,327$1,363,3530.01%
TUDOR INVESTMENT CORP ET AL 19,719$6350.01%
Trexquant Investment LP 10,655$343,1980.01%
CANADA PENSION PLAN INVESTMENT BOARD 167,568$5,397,3650.01%
State of New Jersey Common Pension Fund D 70,221$2,261,8180.01%
AMERICAN INTERNATIONAL GROUP, INC. 38,967$1,255,1270.01%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q1 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.